Replies to post #4509 on Revance Therapeutics Inc (RVNC)

[Emannow]

Hi Dew, as the shorts continue to drive the RVNC stock price down, does this open the doors for a hostile takeover or buyout?

Botox is now the 5th largest quarterly revenue product for Abbive as the Therapeutic sales continue to grow! With Daxi and the amazing Therapeutic application, Daxi will in a few years take Therapeutic market share and become a very profitable division for any pharmaceutical company!

Thank you Dew!